A Study to Evaluate the Safety and Efficacy of SHR-1210, Gemcitabine and Cis-platinum by R/M NPC Subjects
Status:
Unknown status
Trial end date:
2019-08-01
Target enrollment:
Participant gender:
Summary
This is an open-label, single center, non-randomized, phase I trial to evaluate safety and
efficacy of using the combination treatment of SHR-1210, gemcitabine and cis-platinum by
recurrent and metastatic NPC.